Just two games into the Indian Premier League (IPL) 2026 season, but Punjab Kings look like a team possessed, a unit that is determined to repeat last season's heroics, which saw them reach the final, ...

ABSTRACT: The search of mineral resources and potential mineralization zones is one of the most demanding activities in the mining domain. This activity requires the use of appropriate methods that ...

FIRST ON FOX: The origins of a fraud-fighting technology now used by one of the world’s largest insurers trace back to a deadly insider attack during the Iraq War. Clearspeed founder Alex Martin was ...

Matthew Herper covers medical innovation — both its promise and its perils. Food and Drug Administration official Vinay Prasad self-destructed last week. The FDA announced Friday evening that he would ...

The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the end of April. FDA commissioner Dr. Marty Makary posted ...

Successor to be named before Prasad's departure Prasad had received criticism for his division's handling of rare disease treatments Prasad to return to UCSF March 6 (Reuters) - The controversial head ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Vinay Prasad, a top ...

Center for Biologics Evaluation and Research Director Vinay Prasad will exit the FDA for the second time after a controversial run that saw the oncologist butt heads with colleagues and ruffle ...

Aside from creating a toxic work environment, CBER Director Vinay Prasad has also been accused of berating his staff and retaliating against reviewers who questioned his decisions. The FDA is ...

The West Virginia Department of Health has appointed Carrie Jeffries and Dr. Soumya Prasad to lead the state’s Rural Health Transformation program, the agency announced Friday. The appointments of ...

WASHINGTON—In an hour-long meeting in January, Food and Drug Administration career staff laid out their objections to a plan to block a new flu shot from vaccine maker Moderna. They argued that ...